Oral Corona Virus Vaccine..And Company Stock Rise By Investing.com

Oral Corona Virus Vaccine..And Company Stock Rise By Investing.com
Oral Corona Virus Vaccine..And Company Stock Rise By Investing.com

© Reuters

Investing.com – Merck is seeking emergency authorization for an oral coronavirus treatment after “compelling results” from its trials, CNBC reports.

Merck and Ridgeback Biotherapeutics plan to seek emergency authorization for an oral antiviral treatment for Covid-19, after the drug showed “convincing results” in clinical trials. The companies announced on Friday that molnopiravir reduced the risk of hospitalization or death by about 50% for patients with mild or moderate cases of COVID-19. Molnopiravir is given orally and works by preventing the multiplication of Covid-19 inside the body.

An interim analysis of the Phase 3 study showed that 7.3% of patients treated with molnopiravir were hospitalized within 29 days. Among the placebo-treated patients, 14.1% were hospitalized or died by day 29. No deaths were reported in patients treated with molnopiravir over the 29-day period, while 8 deaths were reported in placebo-treated patients.

All 775 participants in the trial had laboratory-confirmed symptoms of Covid-19 and were randomly assigned to either mollopiravir or a placebo within five days of symptoms starting.

Not every participant was vaccinated and had at least one underlying factor that puts them at greater risk of developing a more serious case of the virus. The most common risk factors included obesity, being over the age of 60, diabetes and heart disease.

Shares of Merck & Co. (NYSE:) jumped more than 7% after the news was traded before the markets opened.

Explanation of the risks: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Oral Corona Virus VaccineAnd Company Stock Rise Investingcom

For Latest Updates Follow us on Google News

PREV Minister Ze’ev Elkin revealed: This is what was inside the bag I kept with Putin
NEXT Millions of “Android”, “Windows” and “iPhone” users may lose access to the Internet